Patricia-Marie Charpentier

Title: The Innovations of Patricia-Marie Charpentier

Introduction

Patricia-Marie Charpentier is a notable inventor based in Maintal, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of LH-RH antagonists. Her work has implications for various medical applications, showcasing her expertise and innovative spirit.

Latest Patents

Charpentier holds a patent for "LH-RH antagonists having improved action." This patent discloses new LH-RH antagonists, specifically peptidomimetics and peptides modified in a side chain. The patent also covers their salts with pharmaceutically acceptable acids and a process for preparing these LH-RH antagonists and their salts. The disclosed peptides represent analogues of the luteinising hormone releasing hormone (LH-RH). These compounds exhibit high antagonistic power while being free of undesirable side effects, particularly edematogenic effects.

Career Highlights

Charpentier is associated with Asta Medica Aktiengesellschaft, where she has been able to apply her innovative ideas in a collaborative environment. Her work has not only advanced the understanding of LH-RH antagonists but has also contributed to the pharmaceutical industry’s efforts to develop safer and more effective treatments.

Collaborations

Throughout her career, Charpentier has worked alongside esteemed colleagues such as Bernhard Kutscher and Michael Bernd. These collaborations have enriched her research and have led to significant advancements in her field.

Conclusion

Patricia-Marie Charpentier's contributions to the development of LH-RH antagonists highlight her role as an influential inventor in the pharmaceutical industry. Her innovative work continues to pave the way for advancements in medical treatments.